RBCL (RBCL) Stock Price & Analysis
RBCL (RBCL) rose 0.00% to USD 0 as of June 10, 2026 at 12:53 UTC, according to Nexqual real-time market data.
RBCL last closed at USD 0; the session ranged USD 0–0 on volume of 2,125 shares. Market capitalization is $1,549, with a 52-week range of USD 0–0 (PNK). Source: Nexqual, June 10, 2026 at 12:53 UTC.
Key Statistics (as of June 10, 2026 at 12:53 UTC)
| Price | USD 0 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0 |
| Open | USD 0 |
| Day Range | USD 0 – 0 |
| 52-Week Range | USD 0 – 0 |
| Volume | 2,125 shares |
| Market Cap | $1,549 |
| Exchange | PNK |
Technical Analysis (RBCL)
Nexqual's technical model rates RBCL "STRONG SELL" based on 0 bullish and 5 bearish signals across 124 daily candles, as of June 10, 2026 at 12:53 UTC.
| Overall Signal | STRONG SELL |
|---|---|
| RSI (14) | 100 (overbought) |
| vs SMA50 | Below (USD 0) |
| MACD | 0 (negative) |
Analyst Ratings (RBCL)
Wall Street analysts rate RBCL "None", per Nexqual as of June 10, 2026 at 12:53 UTC.
| Consensus Rating | None |
|---|
Earnings (RBCL)
Source: Nexqual, June 10, 2026 at 12:53 UTC.
Financials & Fundamentals (RBCL)
| Total Revenue | $24.12M |
|---|---|
| Revenue Growth (YoY) | -28.10% |
| Gross Margin | +56.90% |
| Operating Margin | -21.18% |
| Profit Margin | -2.32% |
| ROE | -6.77% |
| Current Ratio | 2.16 |
| Total Cash | $2.09M |
| Total Debt | $0 |
| Free Cash Flow | $-2.59M |
Source: Nexqual, June 10, 2026 at 12:53 UTC.
Financial Health Score (RBCL)
Nexqual rates RBCL's overall financial health "Weak" across five dimensions, as of June 10, 2026 at 12:53 UTC.
| Growth | Critical — Revenue -28% YoY (latest Q), sharp decline |
|---|---|
| Profitability | Weak — Not yet profitable — scaling phase |
| Balance Sheet | Mixed — $2M cash, no debt |
| Cash Flow | Weak — FCF negative: -$3M, burning cash |
| Efficiency | Critical — ROE -7%, ROA -10.0% |
Ownership (RBCL)
| Insider Ownership | +8.31% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 2.21M |
Source: Nexqual, June 10, 2026 at 12:53 UTC.
Leadership (RBCL)
RBCL is led by David Price, Acting Chief Executive Officer, per Nexqual as of June 10, 2026 at 12:53 UTC.
| Acting Chief Executive Officer | David Price |
|---|---|
| Founder & Chairman | Clinton H. Howard (age 97) |
| Senior Vice President of Operations | Kenneth L. Sabot (age 80) |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| PCYN | Procyon Corp. | USD 0.2 | ▲ 0% |
| QMDT | QUICK-MED TECHNOLOGIES INC | USD 0 | ▲ 0% |
| IAGX | IMAGENETIX INC | USD 0 | ▲ 0% |
| SCND | Scientific Industries, Inc. | USD 0.7 | ▼ 6.04% |
| DAAT | DAC Technologies Group Internat | USD 0.02 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 12:53 UTC. This page is informational and not investment advice.